Doylestown, PA, United States of America

Peter G Glavinos


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Peter G Glavinos

Introduction

Peter G Glavinos is an accomplished inventor based in Doylestown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs that enhance the delivery of nonsteroidal and steroidal agents. His innovative work has the potential to improve treatment options for various medical conditions.

Latest Patents

Peter G Glavinos holds a patent for "Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents." This patent describes prodrugs that contain an active drug molecule linked to a polyethylene glycol group. The exemplary soluble ester prodrugs include compounds such as naproxen, triamcinolone acetonide, gancyclovir, taxol, cyclosporin, dideoxyinosine, trihydroxy steroids, and flurbiprofen molecules linked to polyethylene glycol (PEG) groups. The patent also outlines pharmaceutical compositions containing these prodrugs and methods for using these esters to treat various disease states or symptoms.

Career Highlights

Peter G Glavinos is associated with the University of Kentucky Research Foundation, where he has been instrumental in advancing research in pharmaceutical sciences. His work has garnered attention for its innovative approach to drug delivery systems.

Collaborations

Peter has collaborated with notable colleagues, including Paul Ashton and Thomas J Smith. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Peter G Glavinos is a notable inventor whose work in developing prodrugs has the potential to transform pharmaceutical treatments. His contributions to the field are significant and continue to influence research and development in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…